Effects of methotrexate on the developments of heart and vessel in zebrafish

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 1, 2009, Pages 86-96

  Sun, Shuna ^a   Gui, Yonghao ^a   Wang, Yuexiang ^a   Qian, Linxi ^a   Liu, Xuefei ^a   Jiang, Qiu ^a   Song, Houyan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Folic acid; Gene transcript level; Heart; Methotrexate; Vessel; Zebrafish

Indexed keywords

DANIO RERIO;

DIHYDROFOLATE REDUCTASE; FOLINIC ACID; METHOTREXATE; PRIMER DNA;

ANIMAL; ARTICLE; BLOOD VESSEL; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; GENETICS; HEART; IN SITU HYBRIDIZATION; MICROINJECTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRENATAL DEVELOPMENT; ZEBRA FISH;

ANIMALS; BASE SEQUENCE; BLOOD VESSELS; DNA PRIMERS; FLUORESCEIN ANGIOGRAPHY; HEART; IN SITU HYBRIDIZATION; LEUCOVORIN; METHOTREXATE; MICROINJECTIONS; POLYMERASE CHAIN REACTION; TETRAHYDROFOLATE DEHYDROGENASE; ZEBRAFISH;

EID: 64049113790     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmn010     Document Type: Article

References (26)

1. Bonnet D. Epidemiology and genetics of congenital heart diseases and cardiomyopathies in children. Rev Prat 2006, 56: 599-604.
2. Botto LD and Correa A. Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Progr Pediatr Cardiol 2003, 18: 111-121.
3. Bailey LB and Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005, 81: 1213S-1217S.
4. Hernandez-Diaz S, Werler MM and Walker AM. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000, 343: 1608-1614.
5. Kao TT, Wang KC and Chang WN. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases-inhibition by folic acid and polyphenols. Drug Metab Dispos 2008, 36: 508-516.
6. Burgoon JM, Selhub J and Nadeau M. Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 2002, 65: 219-227.
7. Li D and Rozen R. Maternal folate deficiency affects proliferation, but not apoptosis, in embryonic mouse heart. J Nutr 2006, 136: 1774-1778.
8. Tang LS, Wlodarczyk BJ and Santillano DR Developmental consequences of abnormal folate transport during murine heart morphogenesis. Birth Defects Res A Clin Mol Teratol 2004, 70: 449-458.
9. Teraoka H, Dong W and Hiraga T. Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom (Kyoto) 2003, 43: 123-132.
10. Sehnert AJ, Huq A and Weinstein BM. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 2002, 31: 106-110.
11. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio). Eugene, OR: University of Oregon Press, 1993, pp. 3.1-3.26.
12. Kimmel CB, Ballard WW and Kimmel SR. Stages of embryonic development of the zebrafish. Dev Dyn 1995, 203: 253-310.
13. Shu X, Cheng K and Patel N. Na,K-ATPase is essential for embryonic heart development in the zebrafish. Development 2003, 130: 6165-6173.
14. Wang YX, Qian LX, Yu Z and Jiang Q. Requirements of myocytespecific enhancer factor 2A in zebrafish cardiac contractility. FEBS Lett 2005, 79: 4843-4850.
15. Yelon D, Horne SA and Stainier DYR. Restricted expression of cardiac myosin genes reveals regulated aspects of heart tube assembly in zebrafish. Dev Biol 1999, 214: 23-37.
16. Berdougo E, Coleman H and Lee DH. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development 2003, 130: 6121-6129.
17. Dai YS and Cserjesi P. The basic helix-loop-helix factor, HAND2, functions as a transcriptional activator by binding to E-boxes as a heterodimer. J Biol Chem 2002, 277: 12604-12612.
18. Zhao Y, Samal E and Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436: 214-220.
19. Zeisberg EM, Ma Q and Juraszek AL. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 2005, 115: 1522-1531.
20. Aiyer AR, Honarpour N and Herz J. Loss of Apaf-1 leads to partial rescue of the HAND2-null phenotype. Dev Biol 2005, 278: 155-162.
21. Yelon D. Cardiac patterning and morphogenesis in zebrafish. Dev Dyn 2001, 222: 552-563.
22. van Oort RJ, van Rooij E and Bourajjaj M. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 2006, 114: 298-308.
23. Vong L, Bi W and O'Connor-Halligan KE. MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field. Dev Dyn 2006, 235: 1809-1821.
24. Morin S, Charron F and Robitaille L. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J 2000, 19: 2046-2055.
25. Liang D, Chang JR and Chin AJ. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev 2001, 108: 29-43.
26. Zhong TP, Childs S and Leu JP. Gridlock signalling pathway fashions the first embryonic artery. Nature 2001, 414: 216-220.